Curative anticoagulation prevents endothelial lesion in COVID‐19 patients
Authors:
- 18 June 2020
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 18 (9) , 2391-2399
Abstract
No abstract availableKeywords
Funding Information
- Agence Nationale de la Recherche (SARCODO)
This publication has 31 references indexed in Scilit:
- Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical WorseningPLOS ONE, 2013
- Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosisAngiogenesis, 2012
- Distinct patterns of circulating endothelial cells in pulmonary hypertensionEuropean Respiratory Journal, 2010
- Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competenceJournal of Cellular and Molecular Medicine, 2009
- Circulating Endothelial CellsCirculation, 2009
- Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocolJournal of Thrombosis and Haemostasis, 2006
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Circulating Endothelial Cell Count as a Diagnostic Marker for Non–ST-Elevation Acute Coronary SyndromesCirculation, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Receiver Operating Characteristic (ROC) Curve: Practical Review for RadiologistsKorean Journal of Radiology, 2004